Vera Therapeutics (VERA) Current Assets (2020 - 2026)

Vera Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $615.8 million for Q1 2026.

• Quarterly Current Assets rose 1.6% year-over-year to $615.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $615.8 million (up 1.6% YoY) and the FY2025 annual result came in at $728.9 million, up 11.93% from the prior year.
• Current Assets was $615.8 million for Q1 2026 at Vera Therapeutics, down from $728.9 million in the prior quarter.
• Across five years, Current Assets topped out at $728.9 million in Q4 2025 and bottomed at $125.0 million in Q3 2022.
• A 5-year average of $361.7 million and a median of $364.1 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets jumped 278.56% — and 2026, when it grew 1.6%.
• Vera Therapeutics' Current Assets stood at $125.7 million in 2022, then jumped by 36.85% to $172.0 million in 2023, then soared by 278.56% to $651.2 million in 2024, then gained by 11.93% to $728.9 million in 2025, then decreased by 15.51% to $615.8 million in 2026.
• Business Quant data shows VERA's Current Assets at $615.8 million in Q1 2026, $728.9 million in Q4 2025, and $511.3 million in Q3 2025.